Murine soluble FcɛRII: a molecule in search of a function

This publication has 32 references indexed in Scilit:

• Inhibition of Interleukin‐3‐Dependent Growth of CD34⁺ Acute Myelogenous Leukemia Cells by Recombinant Soluble CD23^a
  Annals of the New York Academy of Sciences, 1991
• Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis
  European Journal of Immunology, 1991
• Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells
  European Journal of Immunology, 1991
• Fc_εRII/CD23: The Low Affinity Receptor for IgE
  Annual Review of Immunology, 1990
• IgE synthesis
  Current Opinion in Immunology, 1990
• Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.
  The Journal of Experimental Medicine, 1990
• Inhibition of human interleukin 4‐induced IgE synthesis by a subset of anti‐CD23/FcϵRII monoclonal antibodies
  European Journal of Immunology, 1990
• Mechanisms of formation of IgE-binding factors (soluble CD23)—I. Fcϵ R II bearing B cells generate IgE-binding factors of different molecular weights
  Molecular Immunology, 1989
• Molecular structure of human lymphocyte receptor for immunoglobulin E
  Cell, 1986
• Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.
  Journal of Clinical Investigation, 1975